1. Adipose tissue-derived metabolite risk scores and risk for type 2 diabetes in South Asians
- Author
-
Gadgil, Meghana D, Cheng, Jing, Herrington, David M, Kandula, Namratha R, and Kanaya, Alka M
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,Medical Biochemistry and Metabolomics ,Nutrition and Dietetics ,Digestive Diseases ,Nutrition ,Liver Disease ,Clinical Research ,Prevention ,Cardiovascular ,Obesity ,Diabetes ,2.1 Biological and endogenous factors ,Aetiology ,Metabolic and endocrine ,Oral and gastrointestinal ,Humans ,Middle Aged ,Diabetes Mellitus ,Type 2 ,Female ,Male ,Aged ,Adult ,Risk Factors ,Aged ,80 and over ,Intra-Abdominal Fat ,Adipose Tissue ,Asian People ,Cohort Studies ,Adiposity ,South Asian People ,Medical and Health Sciences ,Education ,Endocrinology & Metabolism ,Biomedical and clinical sciences ,Health sciences - Abstract
BackgroundSouth Asians are at higher risk for type 2 diabetes (T2D) than many other race/ethnic groups. Ectopic adiposity, specifically hepatic steatosis and visceral fat may partially explain this. Our objective was to derive metabolite risk scores for ectopic adiposity and assess associations with incident T2D in South Asians.MethodsWe examined 550 participants in the Mediators of Atherosclerosis in South Asians Living in America (MASALA) cohort study aged 40-84 years without known cardiovascular disease or T2D and with metabolomic data. Computed tomography scans at baseline assessed hepatic attenuation and visceral fat area, and fasting serum specimens at baseline and after 5 years assessed T2D. LC-MS-based untargeted metabolomic analysis was performed followed by targeted integration and reporting of known signals. Elastic net regularized linear regression analyses was used to derive risk scores for hepatic steatosis and visceral fat using weighted coefficients. Logistic regression models associated metabolite risk score and incident T2D, adjusting for age, gender, study site, BMI, physical activity, diet quality, energy intake and use of cholesterol-lowering medication.ResultsAverage age of participants was 55 years, 36% women with an average body mass index (BMI) of 25 kg/m2 and 6% prevalence of hepatic steatosis, with 47 cases of incident T2D at 5 years. There were 445 metabolites of known identity. Of these, 313 metabolites were included in the MET-Visc score and 267 in the MET-Liver score. In most fully adjusted models, MET-Liver (OR 2.04 [95% CI 1.38, 3.03]) and MET-Visc (OR 2.80 [1.75, 4.46]) were associated with higher odds of T2D. These associations remained significant after adjustment for measured adiposity.ConclusionsMetabolite risk scores for intrahepatic fat and visceral fat were strongly related to incident T2D independent of measured adiposity. Use of these biomarkers to target risk stratification may help capture pre-clinical metabolic abnormalities.
- Published
- 2024